An MIT spin-off is working to restore critical materials production in the US while eliminating toxic byproducts. Named 6K, ...

Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based ...

Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based non-profit BioBridge Global and a recognized leader in ...

For spray-based ionization sources, the exact influence of the droplet charge on the ionization process of proteins is not entirely understood. The decoupling of droplet production and charging in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for ... It is transient, and we have a therapist on ...

STB&T will also deliver valuable feedback on the system’s commissioning process and operational performance. The FrontlineODP™ System produces “on demand” spray dried plasma, an innovative ...

Credit: HFIPS China’s EAST project has set a new global record by maintaining a high-confinement plasma state for over 17 minutes, paving the way for future clean energy solutions by mimicking the sun ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

So is inducing nuclear fusion in the plasma. Both are definitely feats worth attempting because the International Atomic Energy Association rates the energy output of a fusion reaction as nearly four ...

Over the last several years, it has consistently broken fusion records, and it can now add a new one to its collection: the longest sustained ultra-hot plasma. They kept it going for 1,066 seconds ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato ... through its Priority Review process after receiving results from a ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...